For more news, subscribe
Foreign Ministry: Johnson & Johnson selects Peru for COVID-19 vaccine trials.
The Ministry of Foreign Affairs reported that the US company Johnson & Johnson and its pharmaceutical group Janssen selected Peru to participate in phase 3 of the clinical study of its candidate vaccine against the coronavirus, which leaves 27,813 deaths in the country and more than 600 000 infections.
For more than a month, Johnson & Johnson has been evaluating potential sites for its trial, considering criteria such as the epidemiological profile of the countries, the conditions of their research infrastructure and the regulatory approval process.
“Peru, through close work with the company, has complied with the established requirements, demonstrating its commitment to contribute to the solution of the COVID-19 pandemic,” the Foreign Ministry said in a statement.
The Ministry of Foreign Affairs indicated that phase 2 of the Johnson & Johnson clinical study is currently being developed in the United States and Belgium. The results of this phase are expected to be available in September, after which phase 3 would begin.
The phase 3 clinical study will draw 60,000 volunteers between the ages of 18 and 60 worldwide. “The participation of Peruvian citizens will make it possible to contribute to international efforts to develop a safe and effective vaccine against COVID-19 that allows controlling the spread of the SARS-CoV-2 virus and reactivating economies,” said the Ministry of Foreign Affairs.
THE CORONAVIRUS FIGURES.
The Ministry of Health (Minsa) reported today that to date 27,813 deaths and 600,438 infections with COVID-19 have been registered at the national level.
In its latest report, the portfolio indicated that there are currently 13,367 patients hospitalized for COVID-19, of which 1,525 are in the ICU with mechanical ventilation.
Of the total confirmed cases, 407,301 people completed their period of home isolation or were discharged from a health facility.
Video originally published at https://www.youtube.com/watch?v=WLX2ioT70dc
Originally published at https://citynewsmiami.com/index.php/2022/05/20/peru-news-foreign-ministry-johnson-johnson-selects-peru-for-covid-19-vaccine-trials/?utm_source=rss&utm_medium=rss&utm_campaign=peru-news-foreign-ministry-johnson-johnson-selects-peru-for-covid-19-vaccine-trials
The post Peru News: Foreign Ministry: Johnson & Johnson selects Peru for COVID-19 vaccine trials first appeared on Miami Observer News.